nodes	percent_of_prediction	percent_of_DWPC	metapath
Enoxacin—TOP2A—Epirubicin—ovarian cancer	0.595	0.653	CbGbCtD
Enoxacin—TOP2A—Doxorubicin—ovarian cancer	0.316	0.347	CbGbCtD
Enoxacin—TOP2A—G0 and Early G1—RBL2—ovarian cancer	0.00415	0.0706	CbGpPWpGaD
Enoxacin—TOP2A—Docetaxel—Paclitaxel—ovarian cancer	0.00287	0.219	CbGdCrCtD
Enoxacin—TOP2A—myometrium—ovarian cancer	0.00266	0.159	CbGeAlD
Enoxacin—TOP2A—Irinotecan—Topotecan—ovarian cancer	0.00246	0.187	CbGdCrCtD
Enoxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—TP63—ovarian cancer	0.00222	0.0379	CbGpPWpGaD
Enoxacin—CYP1A2—Sulindac Metabolic Pathway—CYP1B1—ovarian cancer	0.00214	0.0365	CbGpPWpGaD
Enoxacin—TOP2A—Retinoblastoma (RB) in Cancer—BARD1—ovarian cancer	0.00209	0.0355	CbGpPWpGaD
Enoxacin—TOP2A—uterine cervix—ovarian cancer	0.00207	0.124	CbGeAlD
Enoxacin—TOP2A—decidua—ovarian cancer	0.00197	0.118	CbGeAlD
Enoxacin—TOP2A—endometrium—ovarian cancer	0.00187	0.112	CbGeAlD
Enoxacin—TOP2A—G0 and Early G1—CCNE1—ovarian cancer	0.00185	0.0316	CbGpPWpGaD
Enoxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—YAP1—ovarian cancer	0.00183	0.0311	CbGpPWpGaD
Enoxacin—TOP2A—Vindesine—Vinorelbine—ovarian cancer	0.00182	0.139	CbGdCrCtD
Enoxacin—TOP2A—uterus—ovarian cancer	0.00172	0.103	CbGeAlD
Enoxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—FASN—ovarian cancer	0.00149	0.0254	CbGpPWpGaD
Enoxacin—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—ovarian cancer	0.00147	0.0251	CbGpPWpGaD
Enoxacin—TOP2A—bone marrow—ovarian cancer	0.00146	0.0875	CbGeAlD
Enoxacin—TOP2A—Paclitaxel—Docetaxel—ovarian cancer	0.00143	0.109	CbGdCrCtD
Enoxacin—TOP2A—female gonad—ovarian cancer	0.00141	0.0843	CbGeAlD
Enoxacin—TOP2A—vagina—ovarian cancer	0.0014	0.0838	CbGeAlD
Enoxacin—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—ovarian cancer	0.00134	0.0228	CbGpPWpGaD
Enoxacin—TOP2A—testis—ovarian cancer	0.00125	0.0748	CbGeAlD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CD82—ovarian cancer	0.00125	0.0212	CbGpPWpGaD
Enoxacin—TOP2A—Gastric Cancer Network 1—APC—ovarian cancer	0.00119	0.0202	CbGpPWpGaD
Enoxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—ovarian cancer	0.00116	0.0197	CbGpPWpGaD
Enoxacin—TOP2A—Mitotic G1-G1/S phases—RBL2—ovarian cancer	0.00108	0.0183	CbGpPWpGaD
Enoxacin—TOP2A—Retinoblastoma (RB) in Cancer—SKP2—ovarian cancer	0.00102	0.0173	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TOP1—ovarian cancer	0.00102	0.0173	CbGpPWpGaD
Enoxacin—CYP1A2—Estrogen Receptor Pathway—CYP1B1—ovarian cancer	0.000998	0.017	CbGpPWpGaD
Enoxacin—TOP2A—Vincristine—Vinorelbine—ovarian cancer	0.000984	0.075	CbGdCrCtD
Enoxacin—TOP2A—Circadian rythm related genes—TOP1—ovarian cancer	0.000976	0.0166	CbGpPWpGaD
Enoxacin—TOP2A—lymph node—ovarian cancer	0.000906	0.0542	CbGeAlD
Enoxacin—TOP2A—Circadian rythm related genes—PPP1CC—ovarian cancer	0.000853	0.0145	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—RSF1—ovarian cancer	0.000838	0.0143	CbGpPWpGaD
Enoxacin—TOP2A—Vinblastine—Vinorelbine—ovarian cancer	0.000792	0.0603	CbGdCrCtD
Enoxacin—CYP1A2—Estrogen metabolism—CYP1B1—ovarian cancer	0.00077	0.0131	CbGpPWpGaD
Enoxacin—TOP2A—Gastric Cancer Network 2—CTNNB1—ovarian cancer	0.000764	0.013	CbGpPWpGaD
Enoxacin—TOP2A—Circadian rythm related genes—HNF1B—ovarian cancer	0.00074	0.0126	CbGpPWpGaD
Enoxacin—TOP2A—Mitotic G1-G1/S phases—SKP2—ovarian cancer	0.000717	0.0122	CbGpPWpGaD
Enoxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCNE1—ovarian cancer	0.000684	0.0116	CbGpPWpGaD
Enoxacin—CYP1A2—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.00068	0.0116	CbGpPWpGaD
Enoxacin—TOP2A—Retinoblastoma (RB) in Cancer—TYMS—ovarian cancer	0.000671	0.0114	CbGpPWpGaD
Enoxacin—CYP1A2—Estrogen Receptor Pathway—ESR1—ovarian cancer	0.000627	0.0107	CbGpPWpGaD
Enoxacin—TOP2A—Gastric Cancer Network 2—MYC—ovarian cancer	0.000619	0.0105	CbGpPWpGaD
Enoxacin—TOP2A—Gastric Cancer Network 2—EGFR—ovarian cancer	0.000606	0.0103	CbGpPWpGaD
Enoxacin—TOP2A—Mitotic G1-G1/S phases—CCND2—ovarian cancer	0.000549	0.00935	CbGpPWpGaD
Enoxacin—CYP1A2—Melatonin metabolism and effects—CYP1B1—ovarian cancer	0.000525	0.00894	CbGpPWpGaD
Enoxacin—TOP2A—Mitotic G1-G1/S phases—PPP2R1A—ovarian cancer	0.000518	0.00882	CbGpPWpGaD
Enoxacin—TOP2A—Gastric Cancer Network 2—TP53—ovarian cancer	0.000508	0.00865	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	0.000486	0.00827	CbGpPWpGaD
Enoxacin—TOP2A—Mitotic G1-G1/S phases—CCNE1—ovarian cancer	0.000481	0.00819	CbGpPWpGaD
Enoxacin—TOP2A—Idarubicin—Epirubicin—ovarian cancer	0.00048	0.0365	CbGdCrCtD
Enoxacin—TOP2A—Doxorubicin—Epirubicin—ovarian cancer	0.00048	0.0365	CbGdCrCtD
Enoxacin—TOP2A—Daunorubicin—Epirubicin—ovarian cancer	0.00048	0.0365	CbGdCrCtD
Enoxacin—TOP2A—Mitotic G1-G1/S phases—TYMS—ovarian cancer	0.000472	0.00804	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	0.000444	0.00756	CbGpPWpGaD
Enoxacin—TOP2A—Epirubicin—Doxorubicin—ovarian cancer	0.000444	0.0338	CbGdCrCtD
Enoxacin—TOP2A—Idarubicin—Doxorubicin—ovarian cancer	0.000444	0.0338	CbGdCrCtD
Enoxacin—TOP2A—Daunorubicin—Doxorubicin—ovarian cancer	0.000444	0.0338	CbGdCrCtD
Enoxacin—TOP2A—Cell Cycle—RAD51C—ovarian cancer	0.00044	0.00749	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—PPP1CC—ovarian cancer	0.00043	0.00732	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	0.000416	0.00708	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—RBL2—ovarian cancer	0.000395	0.00672	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—PPP1CC—ovarian cancer	0.000385	0.00655	CbGpPWpGaD
Enoxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000381	0.00649	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	0.000376	0.0064	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	0.000364	0.0062	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	0.000364	0.0062	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—ovarian cancer	0.000363	0.00618	CbGpPWpGaD
Enoxacin—CYP1A2—Tryptophan metabolism—CYP1B1—ovarian cancer	0.000363	0.00618	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—ovarian cancer	0.000363	0.00618	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	0.000358	0.00609	CbGpPWpGaD
Enoxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—ovarian cancer	0.000354	0.00603	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—RBL2—ovarian cancer	0.000353	0.00601	CbGpPWpGaD
Enoxacin—CYP1A2—Estrogen Receptor Pathway—STAT3—ovarian cancer	0.000351	0.00597	CbGpPWpGaD
Enoxacin—TOP2A—Circadian rythm related genes—TYMS—ovarian cancer	0.000344	0.00585	CbGpPWpGaD
Enoxacin—CYP1A2—Arachidonic acid metabolism—CYP1B1—ovarian cancer	0.00034	0.00578	CbGpPWpGaD
Enoxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—ovarian cancer	0.000338	0.00575	CbGpPWpGaD
Enoxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000294	0.005	CbGpPWpGaD
Enoxacin—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.00029	0.00493	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	0.000278	0.00473	CbGpPWpGaD
Enoxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—ovarian cancer	0.000271	0.00461	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—SKP2—ovarian cancer	0.000263	0.00447	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	0.000263	0.00447	CbGpPWpGaD
Enoxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—ovarian cancer	0.000249	0.00424	CbGpPWpGaD
Enoxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000238	0.00405	CbGpPWpGaD
Enoxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—ovarian cancer	0.000238	0.00405	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—MLH1—ovarian cancer	0.000238	0.00404	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—SKP2—ovarian cancer	0.000235	0.004	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—ovarian cancer	0.000228	0.00388	CbGpPWpGaD
Enoxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—ovarian cancer	0.000223	0.00379	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	0.000204	0.00347	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—CCND2—ovarian cancer	0.000201	0.00343	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—CHEK2—ovarian cancer	0.000192	0.00327	CbGpPWpGaD
Enoxacin—TOP2A—Mitotic G1-G1/S phases—MYC—ovarian cancer	0.000191	0.00325	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—PPP2R1A—ovarian cancer	0.00019	0.00323	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	0.000189	0.00321	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	0.000185	0.00315	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	0.00018	0.00307	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—CCND2—ovarian cancer	0.00018	0.00307	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—BRCA1—ovarian cancer	0.00018	0.00307	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	0.000178	0.00304	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—CCNE1—ovarian cancer	0.000176	0.003	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	0.000174	0.00296	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—TYMS—ovarian cancer	0.000173	0.00295	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—PPP2R1A—ovarian cancer	0.00017	0.00289	CbGpPWpGaD
Enoxacin—TOP2A—Circadian rythm related genes—PTEN—ovarian cancer	0.000167	0.00284	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—BRCA2—ovarian cancer	0.000163	0.00277	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—CCNE1—ovarian cancer	0.000158	0.00268	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	0.000157	0.00267	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—ovarian cancer	0.000156	0.00265	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	0.000155	0.00264	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	0.000155	0.00264	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—TYMS—ovarian cancer	0.000155	0.00264	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	0.000152	0.00258	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	0.000149	0.00253	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	0.000145	0.00246	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	0.000141	0.00241	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	0.000141	0.00241	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—BIRC5—ovarian cancer	0.000139	0.00237	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—TERT—ovarian cancer	0.000135	0.0023	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	0.000134	0.00227	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	0.000129	0.0022	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	0.000127	0.00217	CbGpPWpGaD
Enoxacin—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	0.000126	0.00215	CbGpPWpGaD
Enoxacin—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000125	0.00212	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	0.000123	0.00209	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	0.000119	0.00202	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	0.000119	0.00202	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	0.000116	0.00198	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	0.000116	0.00198	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	0.000116	0.00198	CbGpPWpGaD
Enoxacin—TOP2A—Circadian rythm related genes—TP53—ovarian cancer	0.000114	0.00194	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	0.00011	0.00187	CbGpPWpGaD
Enoxacin—TOP2A—Circadian rythm related genes—IL6—ovarian cancer	0.000104	0.00178	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	0.0001	0.00171	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	9.75e-05	0.00166	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	9.32e-05	0.00159	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	9.14e-05	0.00156	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—CCND1—ovarian cancer	8.72e-05	0.00148	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—CDKN1B—ovarian cancer	8.18e-05	0.00139	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—CCND1—ovarian cancer	7.8e-05	0.00133	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—NME2—ovarian cancer	7.71e-05	0.00131	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—ovarian cancer	7.19e-05	0.00122	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—MYC—ovarian cancer	7e-05	0.00119	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—MAPK1—ovarian cancer	6.85e-05	0.00117	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	6.54e-05	0.00111	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—MAPK3—ovarian cancer	6.43e-05	0.00109	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—MYC—ovarian cancer	6.26e-05	0.00106	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—MAPK1—ovarian cancer	6.12e-05	0.00104	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	5.33e-05	0.000908	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—TP53—ovarian cancer	5.14e-05	0.000875	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—CYTB—ovarian cancer	4.97e-05	0.000846	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	4.86e-05	0.000827	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—BRIP1—ovarian cancer	4.34e-05	0.000739	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—PPP1CC—ovarian cancer	4.34e-05	0.000739	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.17e-05	0.000539	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—YAP1—ovarian cancer	2.91e-05	0.000496	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.88e-05	0.000491	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.53e-05	0.000431	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—FASN—ovarian cancer	2.38e-05	0.000404	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—SLC5A5—ovarian cancer	2.34e-05	0.000398	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—SLC2A1—ovarian cancer	2.26e-05	0.000384	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.21e-05	0.000376	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—CYP1B1—ovarian cancer	2.16e-05	0.000368	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	1.92e-05	0.000327	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.91e-05	0.000325	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—ABCB1—ovarian cancer	1.78e-05	0.000303	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—TYMS—ovarian cancer	1.75e-05	0.000298	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—CAV1—ovarian cancer	1.41e-05	0.00024	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.35e-05	0.000229	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—PIK3CG—ovarian cancer	1.28e-05	0.000219	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—PIK3CD—ovarian cancer	1.13e-05	0.000192	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—PIK3CB—ovarian cancer	9.84e-06	0.000167	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—PTEN—ovarian cancer	8.5e-06	0.000145	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—PIK3CA—ovarian cancer	6e-06	0.000102	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—AKT1—ovarian cancer	4.9e-06	8.34e-05	CbGpPWpGaD
